Clinical Trial

Neurodevelopmental Outcomes in Cerebral Visual Impairment

Study acronym: CVI-ND
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Cerebral visual impairment (CVI) is one of the leading causes of pediatric visual impairment and negatively impacts the development of motor, language, and cognitive skills. This study proposes to (1) establish a novel and easy to use CVI screening algorithm for infants and (2) develop CVI subtypes based on vision, motor, language, and cognition. The overarching goal is to identify CVI early and enhance our comprehension of CVI's impact on a child's development. The results will fundamentally change the approach to designing treatments for children with CVI.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-30.
Trial Details
NCT Number NCT07212010
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Collaborators: National Eye Institute (NEI)
Conditions Cerebral Visual Impairment
Enrollment 600 participants
Start Date 2025-07-31
Primary Completion 2030-08 (estimated)
Study Completion 2031-08 (estimated)
Updated on ClinicalTrials.gov 2025-10-09